Evidence map›Paper›PMID 35332686›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Exosome Processing and Characterization Approaches for Research and Technology Development.

James J Lai, Zoe L Chau, Sheng-You Chen, John J Hill, Katalin V Korpany, Nai-Wen Liang, Li-Han Lin, Yi-Hsuan Lin, Joanne K Liu, Yu-Chung Liu and 2 more

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 373 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
373citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

373 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Natural Product-Derived Vesicles in Nanotherapeutics.Journal of extracellular vesicles · 2026
    Review
  12. Review
  13. Article
  14. Exosome-mediated siRNA delivery in cancer: Loading strategies, targeting approaches, and therapeutic outcomes.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Rab27: Molecular switch of tumor exosome secretion (Review).International journal of molecular medicine · 2026
    Review

313 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

James J LaiDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0003-3437-7810
Zoe L ChauDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
Sheng-You ChenDepartment of Mechanical Engineering, University of Washington, Seattle, WA, 98195, USA.
John J HillDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
Katalin V KorpanyDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0002-9058-8500
Nai-Wen LiangDepartment of Materials Science and Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan.
Li-Han LinDepartment of Mechanical Engineering, National Taiwan University, Taipei City, 10617, Taiwan.
Yi-Hsuan LinDepartment of Engineering and System Science, National Tsing Hua University, Hsinchu, 30013, Taiwan.
Joanne K LiuDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
Yu-Chung LiuDepartment of Materials Science and Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan.
Ruby LundeDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
Wei-Ting ShenDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, 30013, Taiwan.

Funding

MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer diseaseR01AG061383 · NIA · UNIVERSITY OF WASHINGTON · PI SHI, MIN · 2019 to 2023
$3.4M
Placentomics using a novel method to isolate circulating placental derivativesR01HD089679 · NICHD · UNIVERSITY OF WASHINGTON · PI CHIU, DANIEL T, GRAVETT, MICHAEL G · 2016 to 2020
$3.1M
Characterization and quantification of CNS cell specific extracellular microvesicles in bloodR33MH118160 · NIMH · UNIVERSITY OF WASHINGTON · PI SHI, MIN · 2020 to 2022
$2.0M
Characterization and quantification of CNS cell specific extracellular microvesicles in bloodR21MH118160 · NIMH · UNIVERSITY OF WASHINGTON · PI STEWART, TESSANDRA · 2018 to 2019
$424k
NIA NIH HHS R01 AG061383NICHD NIH HHS R01 HD089679NIH HHS AG061383NIH HHS HD089679)NIH HHS MH118160NIMH NIH HHS R21 MH118160NIMH NIH HHS R33 MH118160
6 · The paper itself

Abstract

Exosomes are extracellular vesicles that share components of their parent cells and are attractive in biotechnology and biomedical research as potential disease biomarkers as well as therapeutic agents. Crucial to realizing this potential is the ability to manufacture high-quality exosomes; however, unlike biologics such as proteins, exosomes lack standardized Good Manufacturing Practices for their processing and characterization. Furthermore, there is a lack of well-characterized reference exosome materials to aid in selection of methods for exosome isolation, purification, and analysis. This review informs exosome research and technology development by comparing exosome processing and characterization methods and recommending exosome workflows. This review also provides a detailed introduction to exosomes, including their physical and chemical properties, roles in normal biological processes and in disease progression, and summarizes some of the on-going clinical trials.

Indexed as

ExosomesExtracellular VesiclesIndustrial DevelopmentProteinsProteinsanalytical characterizationsexosome clinical trialsexosomesextracellular vesiclesGood Manufacturing Practicesisolation processesMISEV2018 guidelines

Identifiers

PMID35332686
PMCPMC9130923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.